...

Now Available From CCO Oncology

INDEPENDENT CONFERENCE COVERAGE

Data From the Clinical Oncology Meeting in Chicago

CCO's comprehensive coverage of the clinical oncology meeting in Chicago, Illinois, includes Capsule Summaries of the most clinically relevant data presented at the meeting, audio highlights, original CCO highlights slidesets, and CME/CE-certified Expert Analyses to help you understand the implications of these new data for clinical practice.

To browse available coverage, click here.

CCO Conference Coverage

2010 American Association for Cancer Research Annual Meeting


CME-Certified Conference Report:

/upload/global/headshots/herbst_roy.jpg/upload/global/headshots/hidalgo_manuel.jpg

American Association for Cancer Research 2010 Annual Meeting: Conference Report
Roy S. Herbst, MD, PhD, and Manuel Hidalgo, MD, PhD, discuss the most clinically relevant new data reported at the 2010 annual meeting of the American Association for Cancer Research.

Downloadable Slideset:

Cancer Research 2010
Review a downloadable slideset by Manuel Hidalgo, MD, PhD, covering the most clinically relevant new data reported at the 2010 annual meeting of the American Association for Cancer Research.

CCO Conference Coverage

2010 Oncology Nursing Society Congress

Advanced practice nurses Tracy K. Gosselin, RN, MSN, AOCN, and Sandra E. Kurtin, RN, MS, AOCN, ANP-C, review current thinking and standards of care in the nurse management of cancer patients.


CE-Certified Conference Report:

/upload/global/headshots/gosselin_ tracy.jpg

35th Annual Oncology Nursing Society Congress: Conference Report
Tracy K. Gosselin, RN, MSN, AOCN, and Sandra E. Kurtin, RN, MS, AOCN, ANP-C, discuss current nurse management of patients with cancer based on presentations at the 35th Annual Oncology Nursing Society Congress.

Treatment Update

Clinical Considerations and the Evolving Role of Maintenance Therapy in Advanced NSCLC

Experts discuss the use of maintenance therapy in non-small-cell lung cancer and the optimal management of treatment-induced adverse effects.


Now Available!

Downloadable Slideset:

Clinical Considerations and the Evolving Role of Maintenance Therapy in Advanced NSCLC 
Download slides summarizing an expert roundtable on treatment approaches for maintenance therapy in non-small-cell lung cancer and optimal management of treatment-induced adverse effects.

 CME/CE-Certified Module:

/upload/global/headshots/langer_corey.jpg/upload/global/headshots/socinski_mark.jpg/upload/global/headshots/west_howard.jpg

Clinical Considerations and the Evolving Role of Maintenance Therapy in Advanced NSCLC
Join CCO’s expert faculty members, Corey J. Langer, MD, FACP; Mark Socinski, MD; Howard (Jack) L. West, MD; Beth Eaby-Sandy, MSN, CRNP, OCN; and Victoria Sherry, MSN, CRNP, AOCNP, as they review and explore current and emerging options for maintenance therapy following first-line treatment of patients with advanced non-small-cell lung cancer.

Treatment Update

Clinical Management of Skeletal Integrity in Cancer: The Role of the Oncology Nurse in Optimizing Patient Outcomes

Review modules based on Think Tank discussion focused on important nursing considerations for managing skeletal integrity in cancer patients.


Now Available!

CE-Certified Modules:

Bone Complications in Prostate Cancer
Dawn Camp-Sorrell, MSN, FNP, AOCN, reviews important nursing considerations for managing bone health issues in patients with prostate cancer.
Bone Complications in Multiple Myeloma
Miriam P. Rogers, EdD, APRN, AOCN, reviews nursing considerations and emerging data involved in managing bone complications in patients with multiple myeloma.
Bone Complications in Breast Cancer
Julie C. Martin, MSN, APRN, NP, reviews key nursing considerations for optimizing bone health and managing bone complications in patients with breast cancer.

Treatment Update

Clinical Applications for Managing Skeletal Integrity in the Cancer Patient: Current and Novel Treatment Strategies

This comprehensive educational program includes individual reviews on managing bone compromise in patients with multiple myeloma, breast cancer, and prostate cancer that were guided by proceedings from an independent expert panel of international experts.


CME-Certified Modules:

/upload/global/headshots/lipton_allan.jpg

Treatment and Prevention of Bone Metastases in Breast Cancer
Allan Lipton, MD, explores the biology of bone metastases, the currently available therapeutic options, and novel agents under investigation for preventing and treating bone metastases in women with breast cancer.

Treatment of Myeloma Bone Disease
G. David Roodman, MD, PhD, provides an overview of bone health in the setting of multiple myeloma and discusses optimal management strategies to mitigate bone disease.

Managing Bone Complications in Prostate Cancer
Matthew R. Smith, MD, PhD, explores the biology of bone metastases in men with prostate cancer and discusses current and emerging options for preventing and treating skeletal-related events associated with prostate cancer and its treatment.

Downloadable Slideset:

Skeletal Integrity in Oncology: What Physicians Need to Know
This comprehensive slideset includes clinically-relevant data on the prevention and management of bone complications in patients with breast cancer, prostate cancer, and multiple myeloma based on insights and recommendations of an Independent Expert Panel.

Treatment Update

Clinical Conundrums: Choosing the Best Management Approaches in Patients With Ovarian Cancer

A slide review of the most recent data in the management of patients with ovarian cancer in specific clinical scenarios.

Downloadable PowerPoint Slideset:

Clinical Conundrums: Choosing the Best Management Approaches in Patients With Ovarian Cancer
Download slides on the most recent data on managing patients with ovarian cancer in the frontline and recurrent setting and in specific clinical scenarios.

Treatment Update

Multidisciplinary Approaches and Treatment Considerations for Managing Skeletal Integrity in Cancer Patients

Expert faculty members review the latest clinical data on the management of disease-related and treatment-induced bone complications in patients with multiple myeloma, breast cancer, and prostate cancer.


CME-Certified Module:

/upload/global/headshots/lipton_allan.jpg

Multidisciplinary Approaches and Treatment Considerations for Managing Skeletal Integrity in Cancer Patients
Embedded within this CME-certified learning module are interactive self-assessment questions and case vignettes requiring you to make treatment decisions for patients with cancer-related or treatment-induced bone complications. Allan Lipton, MD; G. David Roodman, MD, PhD; and Matthew R. Smith, MD, PhD, review the latest clinical data on the management of bone complications in patients with multiple myeloma, breast cancer, and prostate cancer.

CME-Certified Interactive Virtual Presentations:

Mitigating Bone Complications in Multiple Myeloma—What’s Current and What’s on the Horizon
In this Interactive Virtual Presentation, G. David Roodman, MD, PhD, provides an overview of the latest data on the prevention and management of disease-related and treatment-induced bone complications in multiple myeloma.

Novel Strategies for Bone-Directed Therapy in Prostate Cancer
Matthew R. Smith, MD, PhD, provides an interactive, case-based overview of the latest data on the prevention and management of disease-related and treatment-induced bone complications in prostate cancer.

/upload/global/headshots/lipton_allan.jpg

Emerging Strategies to Prevent and Manage Bone Compromise in Breast Cancer
In this Interactive Virtual Presentation, Allan Lipton, MD, provides an overview of the latest data on the prevention and management of disease-related and treatment-induced bone complications in breast cancer patients.

Downloadable Slidesets:

Mitigating Bone Complications in Multiple Myeloma—What’s Current and What’s on the Horizon
This downloadable slideset was presented by G. David Roodman, MD, PhD as part of a Master Class symposium and includes an overview of the latest data on the prevention and management of myeloma bone disease.

Novel Strategies for Bone-Directed Therapy in Prostate Cancer
This downloadable slideset was presented by Matthew R. Smith, MD, PhD as part of a Master Class symposium and includes an overview of the latest data on the prevention and management of bone complications in prostate cancer.

Emerging Strategies to Prevent and Manage Bone Compromise in Breast Cancer
This downloadable slideset was presented by Allan Lipton, MD as part of a Master Class symposium and includes an overview of the latest data on disease-related and treatment-induced bone complications in patients with breast cancer.

Management Series

Multiple Myeloma Clinical Management Series 2010

Review relevant studies and apply your skills in the clinical management of multiple myeloma through challenging patient cases, interactive slide presentations, and a case vignette module.


CME-Certified Interactive Case Challenges:

/upload/global/headshots/mazumder_amitabha.jpg

Treatment of Newly Diagnosed Multiple Myeloma in a 74-Year-Old Man With Diabetes and a History of Deep Vein Thrombosis
In this Interactive Case Challenge, Amitabha Mazumder, MD, explores the role of cytogenetics and comorbidities in determining the best treatment approach for an elderly patient with newly diagnosed multiple myeloma.

/upload/global/headshots/singhal_seema.jpg

Treatment of Newly Diagnosed Multiple Myeloma in a Patient Who Is Eligible for Hematopoietic Stem Cell Transplantation
In this Interactive Case Challenge, Seema Singhal, MD, explores the role of stem cell transplantation for the management of multiple myeloma.

/upload/global/headshots/bensinger_william.jpg

Treatment of Multiple Myeloma in a Male Patient Who Is Not a Candidate for Autologous or Allogeneic Stem Cell Transplantation
William I. Bensinger, MD, navigates the nuances of selecting optimal treatment for a 77-year-old man who presents with symptomatic myeloma and existing comorbidities.

CME/CE-Certified Module:

/upload/global/headshots/bensinger_william.jpg/upload/global/headshots/mazumder_amitabha.jpg/upload/global/headshots/singhal_seema.jpg

Advances in the Frontline Treatment of Multiple Myeloma
In this CME/CE-certified learning module, William I. Bensinger, MD; Amitabha Mazumder, MD; and Seema Singhal, MD, review the latest findings on the optimal management of patients with newly diagnosed multiple myeloma.

CME/CE-Certified Interactive Virtual Presentations:

Devising Optimal Salvage Treatment for Relapsed/Refractory Multiple Myeloma
G. David Roodman, MD, PhD, describes the parameters for appropriate selection of effective ltreatment strategies for patients with relapsed or refractory multiple myeloma.

Nursing Considerations in the Treatment of Multiple Myeloma
Kathleen Colson, RN, BSN, BS, discusses nursing management strategies for treatment-related adverse effects in patients with multiple myeloma.

Downloadable Slidesets:

Nursing Considerations in the Treatment of Multiple Myeloma
Kathleen Colson, RN, BSN, BS, discusses nursing management strategies for treatment-related adverse effects in patients with multiple myeloma.

Devising Optimal Salvage Treatment for Relapsed/Refractory Multiple Myeloma
G. David Roodman, MD, PhD, discusses current strategies to optimize treatment outcomes in patients with relapsed or refractory multiple myeloma.

Treatment Update

Truth and Consequences: Antiangiogenic Therapies in Cancer

View a Virtual Presentation on the use of angiogenesis inhibitors to treat cancer, including mechanisms of resistance, tumor flare-up after discontinuation, and potential markers to predict clinical benefit.

CME-Certified Virtual Presentation:

Truth and Consequences: Antiangiogenic Therapies in Cancer
Robert S. Kerbel, PhD, reviews the latest preclinical and clinical findings on the use of angiogenesis inhibitors to treat cancer, including mechanisms of resistance, the relevance of tumor flare-up after discontinuation of antiangiogenic therapy, and potential markers to predict clinical benefit.

Downloadable Slideset:

Truth and Consequences: Antiangiogenic Therapies in Cancer
Download slides on the latest preclinical and clinical findings on the use of angiogenesis inhibitors to treat cancer, including mechanisms of resistance, the relevance of tumor flare-up after discontinuation of antiangiogenic therapy, and potential markers to predict clinical benefit.

CCO Conference Coverage

2010 American Society of Clinical Oncology Annual Meeting

CCO's independent coverage of the 2010 American Society of Clinical Oncology Annual Meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio and video Expert Highlights that focus on key issues highlighted at the conference.


CME/CE-Certified Expert Analysis:

/upload/global/headshots/jones_stephen.jpg/upload/global/headshots/miller_kathy.jpg/upload/global/headshots/pegram_mark.jpg

Breast Cancer
Stephen E. Jones, MD, Kathy D. Miller, MD, and Mark D. Pegram, MD, discuss important clinical studies presented at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting focused on both early and advanced breast cancer.

/upload/global/headshots/fisher_richard.jpg/upload/global/headshots/kantarjian_hagop.jpg/upload/global/headshots/lonial_sagar.jpg

Hematologic Malignancies
CCO’s expert faculty members review the clinical implications of new hematologic cancer data presented at the 2010 ASCO annual meeting.

/upload/global/headshots/grothey_axel.jpg/upload/global/headshots/marshall_john.jpg

Gastrointestinal Cancer
CCO’s expert faculty members discuss the most clinically relevant new data on gastrointestinal cancers presented at the 2010 American Society of Clinical Oncology Annual Meeting.

/upload/global/headshots/mocharnuk_robert.jpg/upload/global/headshots/rini_brian.jpg/upload/global/headshots/vogelzang_nicholas.jpg

Genitourinary Cancer
Brian I. Rini, MD, and Nicholas J. Vogelzang, MD, review the major findings and practice-changing studies presented at the 2010 American Society of Clinical Oncology annual meeting in the setting of genitourinary cancers.

/upload/global/headshots/gandara_david.jpg/upload/global/headshots/west_howard.jpg

Lung Cancer
In this CME-certified module, leading experts review the major findings and practice-changing studies presented for the treatment of NSCLC at the 2010 American Society of Clinical Oncology annual meeting.

/upload/global/headshots/flaherty_keith.jpg/upload/global/headshots/kirkwood_john.jpg

Melanoma
CCO’s expert faculty members discuss advances in melanoma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois, including a range of immunologic and molecularly targeted agents as well as combination therapies.

/upload/global/headshots/herzog_thomas.jpg/upload/global/headshots/monk_bradley.jpg

Ovarian Cancer 
Join CCO’s expert faculty members as they review the clinical implications of research on ovarian cancer presented at the 2010 American Society of Clinical Oncology Annual Meeting.

Downloadable PowerPoint Slidesets:

Breast Cancer
In this downloadable slideset, Stephen E. Jones, MD reviews key data in early and metastatic breast cancer presented at the 2010 American Society of Clinical Oncology Annual Meeting. Click here to download slides.

Hematologic Malignancies
In this downloadable slideset, Nicholas J. DiBella, MD, highlights key lymphoma, chronic myeloid leukemia, chronic myelomonocytic leukemia, and multiple myeloma clinical trials presented at the 2010 American Society of Clinical Oncology Annual Meeting. Click here to download slides.

Gastrointestinal Cancer
In this downloadable slideset, Thomas H. Cartwright, MD highlights key data in the settings of colorectal, pancreatic, and gastric cancers presented at the 2010 American Society of Clinical Oncology Annual Meeting. Click here to download slides.

Genitourinary Cancer
In this downloadable slideset, Nicholas J. Vogelzang, MD reviews key data in prostate cancer and renal cell carcinoma presented at the 2010 American Society of Clinical Oncology Annual Meeting. Click here to download slides.

Treatment Update

Myeloma Nursing Roundtable: Current and Emerging Treatment Strategies

Engaging discussion on nursing considerations for adverse effect management and supportive care issues related to current and emerging treatment options for myeloma.


CME-Certified Module:

/upload/global/headshots/lonial_sagar.jpg Nursing Considerations in Current and Emerging Treatment Approaches in Multiple Myeloma
In this learning module, Kathleen Colson, RN, BSN, BS; Deborah Doss, RN, OCN; Beth Faiman, MSN, CNP, AOCN; Charise Gleason, MSN, ANP-BC, AOCNP; and Sagar Lonial, MD, provide an overview of current options available for the treatment of multiple myeloma and an in-depth analysis of key nursing considerations and supportive care strategies for patients receiving novel therapies.

Treatment Update

Adjuvant Treatment for Breast Cancer: Expert Guidance in Assessing Risk, Predicting Benefit, and Selecting Treatment

Read a comprehensive review of the latest clinical data on the optimal use of adjuvant therapy for patients with early breast cancer.


CME-Certified Module:

/upload/global/headshots/ravdin_peter.jpg

An Overview of the Adjuvant Treatment of Early Breast Cancer
Peter Ravdin, MD, PhD, provides a review of the latest clinical data on the optimal use of adjuvant therapy for patients with early breast cancer.

Interactive Tool:

Adjuvant Treatment for Breast Cancer: Expert Guidance in Assessing Risk, Predicting Benefit, and Selecting Treatment
Use this interactive decision support tool to enter your patient’s specific characteristics, then see what 6 breast cancer experts would choose as their treatment approach.

Treatment Update

Clinical Management of Skeletal Integrity in Cancer: The Role of the Oncology Nurse in Optimizing Patient Outcomes

Review and download slides on nursing strategies for managing bone health in breast cancer, prostate cancer, and multiple myeloma patients.

Downloadable Slideset:

Clinical Management of Skeletal Integrity in Cancer: The Role of the Oncology Nurse in Optimizing Patient Outcomes
Download slides from a recent Oncology Nursing Society satellite symposium on managing skeletal integrity in breast cancer, prostate cancer, and multiple myeloma patients.

Management Series

Evolving Standards of Care in Non-Hodgkin’s Lymphoma: A Clinical Management Series

Listen to Interactive Virtual Presentations with expert faculty members as they highlight relevant clinical data and apply them to cases for treating patients with lymphomas.


CME/CE-Certified Interactive Virtual Presentations:

Diffuse Large B-Cell Lymphoma: Current Standards of Care and Clinical Advances
Christopher R. Flowers, MD, MS, provides an interactive case–based overview of standard and investigational treatment strategies for patients with diffuse large B-cell lymphoma.

Mantle Cell Lymphoma: Is There a Potential for Cure?
Andrew D. Zelenetz, MD, PhD, explores the current and emerging treatment options for patients with mantle cell lymphoma.

The Evolving Treatment Paradigm for Follicular Lymphoma
Philip Bierman, MD, provides an interactive, case-based overview of the latest data supporting optimal management strategies for patients with follicular lymphoma.

Relapsed/Refractory Mantle Cell Lymphoma: Is There a Potential for Cure?
Andrew D. Zelenetz, MD, PhD, reviews the latest data on management strategies for patients with relapsed/refractory mantle cell lymphoma.

Peripheral and Cutaneous T-Cell Lymphomas: Overview and Therapeutic Advances
In this Interactive Virtual Presentation, Kerry J. Savage, MD, MSc, provides a case-based overview of the latest treatment approaches for patients with peripheral and cutaneous T-cell lymphomas.

Downloadable PowerPoint Slidesets:

Diffuse Large B-Cell Lymphoma: Current Standards of Care and Clinical Advances
Download slides focused on the standard and investigational treatment strategies for patients with diffuse large B-cell lymphoma.

Mantle Cell Lymphoma: Is There a Potential for Cure?
Download slides focused on the biology of mantle cell lymphoma, prognostic factors, and current and emerging treatment strategies.

The Evolving Treatment Paradigm for Follicular Lymphoma
Download slides focused on standard and investigational treatment strategies for patients with follicular lymphoma

Relapsed/Refractory Mantle Cell Lymphoma: Is There a Potential for Cure?
Download slides focused on standard and investigational treatment strategies for patients with mantle cell lymphoma in the relapsed setting.

Peripheral and Cutaneous T-Cell Lymphomas: Overview and Therapeutic Advances
Download slides focused on standard and investigational treatment strategies for patients with peripheral and cutaneous T-cell lymphoma.

Treatment Update

Research Update on PARP Inhibition: Emerging Data in Breast, Ovarian, and Other Cancers

Incorporating interactivity through cases, William J. Gradishar, MD, FACP, reviews the mechanism of PARP inhibition and its rationale as a therapeutic pathway and describes recent data using novel PARP inhibitors.

CME-Certified Interactive Virtual Presentation:

/upload/global/headshots/gradishar_william.jpg

Research Update on PARP Inhibition: Emerging Data in Breast, Ovarian, and Other Cancers
In this Interactive Virtual Presentation, William J. Gradishar, MD, FACP, reviews the mechanism of PARP inhibition, its rationale as a therapeutic pathway, and describes recent data using novel PARP inhibitors.

Downloadable Slideset:

Research Update on PARP Inhibition: Emerging Data in Breast, Ovarian, and Other Cancers
Download slides on recent data in PARP inhibitors in breast, ovarian, and other solid tumors.

CCO Conference Coverage

2010 Gastrointestinal Cancers Symposium

Expert discussion of key presentations from the Gastrointestinal Cancers Symposium


CME-Certified Conference Report:

/upload/global/headshots/grothey_axel.jpg/upload/global/headshots/venook_alan.jpg

Gastrointestinal Cancers
In this Conference Report, Axel Grothey, MD, and Alan P. Venook, MD, review the most clinically relevant studies presented at the 2010 Gastrointestinal Cancers Symposium.

CCO Conference Coverage

2010 Genitourinary Cancers Symposium

View 3 Conference Reports and 1 downloadable slideset from the 2010 Genitourinary Cancers Symposium on prostate, renal, bladder, and other cancers.

Now Available!

/upload/global/headshots/petrylak_daniel.jpg/upload/global/headshots/vogelzang_nicholas.jpg

Prostate Cancer
CCO’s expert faculty members review the most clinically relevant new data on prostate cancer presented at the 2010 Genitourinary Cancers Symposium.

/upload/global/headshots/rini_brian.jpg/upload/global/headshots/motzer_robert.jpg

Renal Cell Carcinoma
CCO’s expert faculty members review the most clinically relevant new data on renal cell carcinoma presented at the 2010 Genitourinary Cancers Symposium.

Bladder Cancer and Other Cancers
Join CCO’s expert faculty members as they review the clinical implications of research on bladder cancer and other cancers presented at the 2010 Genitourinary Cancers Symposium.

Treatment Update

Hematology Grand Rounds: Optimal Management Strategies and Novel Agents in Multiple Myeloma

Explore clinical challenges in the treatment of multiple myeloma in military veterans, including initial therapeutic approaches for transplantation-eligible vs transplantation-ineligible patients, the role of maintenance therapy, managing myeloma in patients with comorbidities, and surveillance strategies.


CME-Certified Virtual Presentations:

Frontline Therapy for Newly Diagnosed Multiple Myeloma

Explore an overview of current thinking in multiple myeloma therapy, including first-line options, transplantation, and treatment of nontransplantation-eligible patients.

View a downloadable presentation by G. David Roodman, MD, PhD, discussing considerations for initial treatment of multiple myeloma in military veterans. Click here to download slides.


Relapsed/Refractory Multiple Myeloma: Options for Subsequent Therapy
/upload/global/headshots/mazumder_amitabha.jpg

Amitabha Mazumder, MD, discusses treatment considerations for patients with relapsed or refractory multiple myeloma.

Download slide presentation by Amitabha Mazumder, MD, discussing treatment options for military veterans with relapsed/refractory multiple myeloma. Click here to download slides.


Clinical Implications and Nursing Perspectives for Managing Multiple Myeloma

Joseph M. Tariman, PhC, MN, APRN, BC, OCN, discusses nursing-specific considerations in the clinical management of patients with multiple myeloma.

Download slides by Joseph M. Tariman, PhC, MN, APRN, BC, OCN, reviewing nursing-specific considerations in the clinical management of patients with multiple myeloma. Click here to download slides.

Treatment Update

Head and Neck Cancer: Key Challenges and Emerging Opportunities


CME-Certified Interactive Virtual Presentation:

/upload/global/headshots/langer_corey.jpg Recent Advances in the Treatment of Head and Neck Cancer
In this Interactive Virtual Presentation, Corey J. Langer MD, FACP, leads participants through a case-based review of the latest data on optimal treatment strategies for patients with newly diagnosed and recurrent/metastatic head and neck cancer.
This downloadable slideset provides a case-based review of the latest data on optimal treatment strategies for patients with newly diagnosed and recurrent/metastatic head and neck cancer. Click here to download slides.

Treatment Update

Informed Decisions: Helping Patients Understand the Choice Regarding Anthracyclines in the Adjuvant Treatment of Breast Cancer 

In this Interactive Virtual Presentation, Peter Ravdin, MD, PhD, discusses the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer.


CME-Certified Interactive Virtual Presentation:

/upload/global/headshots/ravdin_peter.jpg Talking With a Patient About Anthracycline- vs Nonanthracycline-Based Chemotherapy
Peter Ravdin, MD, PhD, discusses the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer.
Downloadable slideset on the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer. Click here to download slides.

Treatment Update

A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer

In this CME-certified slideset module, Michael Gnant, MD; Allan Lipton, MD; and Gregory R. Mundy, MD, provide an overview of the molecular mechanisms involved in cancer-related bone disease and summarize the latest data on new therapies for preventing cancer treatment–induced bone loss and skeletal-related events in breast cancer patients.

CME-Certified Slideset Module:

/upload/global/headshots/lipton_allan.jpg A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer
Michael Gnant, MD; Allan Lipton, MD; and Gregory R. Mundy, MD, provide an overview of the molecular mechanisms involved in cancer-related bone disease and summarize the latest data on new therapies for preventing cancer treatment–induced bone loss and skeletal-related events in breast cancer patients.

Downloadable PowerPoint Slideset:

A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer
Downloadable slideset including an overview of the molecular mechanisms of cancer-related bone disease and the latest data on new therapies for preventing cancer treatment–induced bone loss and skeletal-related events in breast cancer patients.

Treatment Update

Clinical Advances in Colorectal Cancer: The Role of Targeted Therapy in the Continuum of Care


CME-Certified Interactive Virtual Presentation:

/upload/global/headshots/venook_alan.jpg Toward Individualized Therapies: Metastatic Colorectal Cancer
Alan P. Venook, MD, explores the future of individualized treatment in patients with colorectal cancer, with a focus on predictive biomarkers.
Download slides reviewing the prospect of individualized treatment in patients with colorectal cancer. Click here to download slides.

CCO Conference Coverage

2009 American Society of Hematology Annual Meeting

CCO's independent Conference Coverage of the 2009 Hematology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Downloadable Slides, and audio Expert Highlights that focus on key issues highlighted at the conference.

Acute Leukemias
Dan Douer, MD; Hagop M. Kantarjian, MD; and  Martin S. Tallman, MD

Lymphomas
James O. Armitage, MD; Richard I. Fisher, MD; and Andre Goy, MD, MPH

Myeloma and Plasma Cell Disorders
Kenneth Anderson, MD; Sagar Lonial, MD; and Paul G. Richardson, MD

Chronic Myeloid Leukemia
Brian Druker, MD; Neil P. Shah, MD, PhD; and Moshe Talpaz, MD

Myelodysplastic Syndromes
Alan F. List, MD; Azra Raza, MD; and  Lewis Silverman, MD

Chronic Lymphocytic Leukemia
Susan M. O’Brien, MD and Kanti Rai, MD

Immune Thrombocytopenic Purpura
Howard Liebman, MD and Keith McCrae, MD

CME-Certified Expert Analyses:

/upload/global/headshots/douer_dan.jpg/upload/global/headshots/kantarjian_hagop.jpg/upload/global/headshots/ravandi_farhad.jpg/upload/global/headshots/tallman_martin.jpg Acute Leukemias
Dan Douer, MD; Hagop M. Kantarjian, MD; Farhad Ravandi, MD; and Martin S. Tallman, MD, discuss the clinical implications of study data presented at the 2009 Hematology meeting on the treatment of AML and ALL.
/upload/global/headshots/fisher_richard.jpg/upload/global/headshots/goy_andre.jpg Lymphomas
In this Expert Analysis, renowned faculty members discuss results from several studies presented at the 2009 American Society of Hematology Annual Meeting that evaluate new treatment approaches in lymphomas.
/upload/global/headshots/anderson_kenneth.jpg/upload/global/headshots/lonial_sagar.jpg/upload/global/headshots/richardson_paul.jpg/upload/global/headshots/stadtmauer_edward.jpg Multiple Myeloma
CCO’s expert faculty members review the most important data in the setting of multiple myeloma reported at the 2009 Hematology meeting.
/upload/global/headshots/druker_brian.jpg/upload/global/headshots/jabbour_elias.jpg/upload/global/headshots/shah_neil.jpg/upload/global/headshots/talpaz_moshe.jpg Chronic Myelogenous Leukemia
Join Brian Druker, MD; Elias Jabbour, MD; Neil P. Shah, MD, PhD; and Moshe Talpaz, MD, as they review the clinical implications of research on chronic myelogenous leukemia presented at the 2009 Hematology meeting.
/upload/global/headshots/list_alan.jpg/upload/global/headshots/raza_azra.jpg/upload/global/headshots/silverman_lewis.jpg Myelodysplastic Syndromes
Alan F. List, MD; Azra Raza, MD; Bart L. Scott, MD, MS; and Lewis Silverman, MD, discuss studies presented at the 2009 Hematology meeting on myelodysplastic syndromes, with a focus on new approaches for patients with high-risk disease and those with disease refractory to hypomethylating agents.
/upload/global/headshots/obrien_susan_2.jpg/upload/global/headshots/rai_kanti.jpg Chronic Lymphocytic Leukemia
Susan M. O’Brien, MD, and Kanti Rai, MD, review the most important data in the setting of chronic lymphocytic leukemia reported at the 2009 American Society of Hematology Annual Meeting.
Immune Thrombocytopenic Purpura
Howard Liebman, MD, and Keith R. McCrae, MD, review and provide their clinical prospective on several important immune thrombocytopenia abstracts presented at the 2009 American Society of Hematology Annual Meeting.

Downloadable PowerPoint Slidesets:

Lymphomas
Download slides on the most compelling data in lymphoma presented at the 2009 Hematology Annual Meeting. Click here to download slides.

Advances in Myeloma
Review highlights of the most clinically relevant studies in multiple myeloma presented at the 2009 Hematology meeting. Click here to download slides.

Acute Leukemias and Myelodysplastic Syndromes
Hagop Kantarjian MD, provides a slideset summary of the most notable studies in ALL, AML, and MDS presented at the 2009 Hematology Annual Meeting. Click here to download slides.

CCO Conference Coverage

2009 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium

CCO's independent coverage of the 2009 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, and audio Expert Highlights that focus on key issues highlighted at the conference.


Early Breast Cancer
Harold J. Burstein, MD, PhD; Peter Ravdin, MD, PhD; Nicholas J. Robert, MD; Jeffrey Smerage, MD, PhD Moderator

Metastatic Breast Cancer

Clifford A. Hudis, MD; Kathy D. Miller, MD; George W. Sledge, Jr., MD; Frankie Holmes, MD, FACP Moderator

Prognosis and Prediction
Paul E. Goss, MD, PhD, FRCPC, FRCP; William J. Gradishar, MD, FACP; Daniel F. Hayes, MD; Robert A. Mocharnuk, MD Moderator

CME-Certified Expert Analyses:

/upload/global/headshots/burstein_harold.jpg/upload/global/headshots/ravdin_peter.jpg/upload/global/headshots/robert_nicholas_v2.jpg/upload/global/headshots/smerage_jeffrey.jpg Early Breast Cancer
Harold J. Burstein, MD, PhD; Peter Ravdin, MD, PhD; Nicholas J. Robert, MD; and Jeffrey B. Smerage, MD, PhD, review and discuss the most pertinent new data and research on early breast cancer presented at the 2009 San Antonio Breast Cancer Symposium.
/upload/global/headshots/holmes_frankie.jpg/upload/global/headshots/hudis_clifford.jpg/upload/global/headshots/miller_kathy.jpg/upload/global/headshots/sledge_george1.jpg Metastatic Breast Cancer
Frankie Ann Holmes, MD, FACP; Clifford A. Hudis, MD; Kathy D. Miller, MD; and George W. Sledge, Jr., MD, discuss the most clinically relevant results in the setting of metastatic breast cancer presented at the 2009 Breast Cancer Symposium.
/upload/global/headshots/goss_paul.jpg/upload/global/headshots/gradishar_william.jpg/upload/global/headshots/hayes_daniel.jpg/upload/global/headshots/mocharnuk_robert.jpg Breast Cancer: Prognosis and Prediction
Paul E. Goss, MD, PhD, FRCPC, FRCP; William J. Gradishar, MD, FACP; Daniel F. Hayes, MD; and Robert S. Mocharnuk, MD, review and discuss several of the most significant abstracts pertaining to prediction and prognosis factors in the setting of breast cancer that were presented at the 2009 Breast Cancer Symposium.


Downloadable PowerPoint Slidesets:

Early Breast Cancer: Highlights
Download slides on the most clinically-relevant data in early breast cancer presented at the 2009 Breast Cancer Annual meeting.
Metastatic Breast Cancer: Highlights
Review highlights of clinically relevant studies in metastatic breast cancer presented at the 2009 Breast Cancer Annual Meeting.

Treatment Update

Spanning the Continuum of Care: Optimizing Patient Outcomes in Multiple Myeloma

CCO’s expert faculty members review current thinking regarding the optimal treatment of multiple myeloma, including survival gains, transplantation, and novel agents.


CME-Certified Modules:

/upload/global/headshots/jagannath_sundar.jpg

Frontline Treatment of Multiple Myeloma: Current Options for Initial Therapy
Sundar Jagannath, MD, reviews options for therapy in treatment-naive transplantation-eligible and transplantation-ineligible patients with multiple myeloma.

/upload/global/headshots/mazumder_amitabha.jpg

Relapsed/Refractory Multiple Myeloma: Options for Subsequent Therapy
Amitabha Mazumder, MD, reviews the management approach to relapsed or refractory disease, highlighting the role for novel therapies and the need for supportive care, while also considering the potential for future drug development.

/upload/global/headshots/lonial_sagar.jpg

Multiple Myeloma: Treatment Options for Special Patient Populations
Sagar Lonial, MD, reviews the latest data on optimizing the treatment of multiple myeloma and discusses specific case patients who present with challenging comorbidities, including high-risk cytogenetic abnormalities, advanced age, and renal impairment.

Treatment Update

Navigating the Therapeutic Pathways for AML and MDS 

Through 4 Virtual Presentations and downloadable slidesets, CCO’s expert faculty members explore the current state-of-the-art AML and MDS treatments. Topics include the role of risk stratification in treatment decision making, outcomes for various therapeutic options such as chemotherapy and transplantation, the latest information on clinical trials, and special clinical issues in AML and MDS such as refractory disease and the role of novel molecular diagnostics. This program is produced in partnership with the National Marrow Donor Program® (NMDP). The NMDP facilitates unrelated donor transplantations, conducts research, provides medical education, and supports patients.


CME-Certified Virtual Presentations:

Incorporating Molecular Data Into Risk Stratification for AML
Steven M. Devine, MD, provides up-to-date information on risk stratification in patients with AML and discusses how data on karyotyping, molecular markers, and age affect treatment choices.
Download a slideset in which Steven Devine, MD, provides up-to-date information on risk stratification in patients with AML, and discusses how this affects treatment choices. Click here to download slides.
The Role of Allogeneic Hematopoietic Cell Transplantation in AML
Frederick R. Appelbaum, MD, explores the changes that have improved outcomes of allogeneic transplantation in patients with acute myeloid leukemia.
Download a slideset in which Frederick Appelbaum, MD, explores the changes improved outcomes of allogeneic transplantation in patients with acute myeloid leukemia. Click here to download slides.
Options for High Risk AML and MDS
Daniel Weisdorf, MD, provides an overview of the considerations for allogeneic transplantation in patients with high-risk AML or those with MDS.
Download a slideset in which Daniel Weisdorf, MD, provides an overview of considerations for allogeneic transplantation in patients with high-risk AML or those with MDS. Click here to download slides.
Advances in AML/MDS: The Role of Multicenter Clinical Trials
Dennis L. Confer, MD, highlights the essential role of multicenter clinical trials in expanding transplantation access and identifying optimal treatment approaches for patients with AML and MDS, including studies available through the Blood and Marrow Transplant Clinical Trials Network.
Download a slideset in which Dennis L. Confer, MD, highlights the essential role of multicenter clinical trials in expanding transplantation access and identifying optimal treatment approaches for patients with AML and MDS. Click here to download slides.

Management Series

Spanning the Spectrum of Care: Clinical Advances and Practical Applications in Lymphoma 

CCO’s expert faculty members explore current and emerging treatment options and approaches for the clinical management of patients with lymphomas, including mantle cell lymphoma, follicular lymphoma, T-cell lymphoma, DLBCL, and Waldenström’s macroglobulinemia.


CME-Certified Modules:

Mechanisms of Action and Clinical Advances in the Treatment of Non-Hodgkin’s Lymphomas
Deborah A. Frieze, PharmD, BCOP, and Alice Mohr, RN, MSN, FNP-BC, provide a broad overview of standard and emerging agents and approaches for the treatment of non-Hodgkin’s lymphomas.

Clinical Considerations and Implications for Optimizing Outcomes in Patients With NHL
Alice Mohr, RN, MSN, FNP-BC, and Deborah A. Frieze, PharmD, BCOP, review dosing regimens, critical safety issues, appropriate preventive care, and supportive care measures associated with the use of various therapeutic modalities for the treatment of non-Hodgkin’s lymphoma.


CME-Certified Interactive Virtual Presentations:

/upload/global/headshots/goy_andre.jpg Evolving Options and Challenges in Mantle Cell Lymphoma
Listen to a virtual presentation by Andre Goy, MD, as he provides a comprehensive overview of evolving treatment options for patients with mantle cell lymphoma, and test your knowledge of treatment options in the cases he presents.
Evolving Options and Challenges in Mantle Cell Lymphoma
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of mantle cell lymphoma

/upload/global/headshots/cheson_bruce.jpg

Indolent B-Cell Disorders: Follicular Lymphoma and Waldenström’s Macroglobulinemia
Listen to a virtual presentation by Bruce D. Cheson, MD, as he provides a comprehensive overview of clinical trial data and recommended treatment approaches for follicular lymphoma and Waldenström’s macroglobulinemia patients and tests your knowledge of treatment options in an evolving patient case.

Indolent B-Cell Disorders: Follicular Lymphoma and Waldenström’s Macroglobulinemia
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of follicular lymphoma and Waldenström’s Macroglobulinemia.

/upload/global/headshots/foss_francine.jpg

Therapeutic Approaches in T-Cell Lymphomas: PTCL and CTCL
Francine Foss, MD, discusses the standard of care and novel agents in development for the treatment of T-cell lymphomas.

Therapeutic Approaches in T-Cell Lymphomas: PTCL and CTCL
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of T-Cell lymphomas.

/upload/global/headshots/fisher_richard.jpg

Clinical Considerations and Strategies for Managing Patients With DLBCL
Richard I. Fisher, MD, discusses clinical considerations and strategies for managing patients with diffuse large B-cell lymphoma.

Clinical Considerations and Strategies for Managing Patients With DLBCL
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of diffuse large B-cell lymphoma.

CCO Downloadable Slideset:


Overview of Treatment Options and Clinical Considerations for Managing NHL Patients
Review a comprehensive overview of current standards of care for lymphoma, including nursing considerations, such as dosing schedules, adverse effects, and improving patient quality of life.

Treatment Update

Novel Developments in the Treatment of Malignant Mesothelioma 

CME-Certified Module:

Novel Developments in the Treatment of Malignant Mesothelioma
Marcelo C. DaSilva, MD, FACS, FCCP, and David J. Sugarbaker, MD, provide an in-depth review of the latest developments in the clinical management of patients with malignant mesothelioma.


CME-Certified Interactive Virtual Presentations:

/upload/global/headshots/vogelzang_nicholas.jpg Contemporary Management of Malignant Pleural Mesothelioma
Nicholas J. Vogelzang, MD, provides an overview of current diagnostic and treatment approaches for patients with malignant pleural mesothelioma.
Nicholas J. Vogelzang, MD, reviews current data that suggest new ways of treatment for this previously difficult-to-treat disease. Click here to download slides.

Treatment Update

Treatment Update on T-Cell Lymphoma

Listen to expert faculty members discuss the latest data and present compelling cases in 2 new Interactive Virtual Presentations and read a comprehensive text-based module focused on clinical advancements for the treatment of T-cell lymphoma, including PTCL and CTCL.

CME-Certified Module:

/upload/global/headshots/oconnor_owen.jpg Recent Clinical Advances and Research Developments in T-Cell Lymphomas
Owen A. O'Connor, MD, PhD, provides a comprehensive overview on standard and emerging agents and approaches for the treatment of T-cell lymphomas.


CME-Certified Interactive Virtual Presentations:

Current and Emerging Treatment Options for Patients With Peripheral T-Cell Lymphoma
Steven M. Horwitz, MD, discusses current and emerging treatment options for patients with peripheral T-cell lymphoma.
    Downloadable slideset on the standards of care and emerging novel therapies for the treatment of peripheral T-cell lymphoma.
/upload/global/headshots/zic_john.jpg Current and Emerging Treatment Options in Cutaneous T-Cell Lymphoma
John A. Zic, MD, discusses the pathogenesis, staging, and treatment options for patients with cutaneous T-cell lymphoma.
    Downloadable slideset on the standards of care and emerging novel therapies for the treatment of cutaneous T-cell lymphoma.

Treatment Update

Idiopathic Thrombocytopenic Purpura (ITP): Shifting the Treatment Paradigm

Explore recent findings regarding idiopathic thrombocytopenic purpura (ITP) through a video module and 6 downloadable slidesets. Topics include ITP etiology, pathophysiology, and review of recent data and expert recommendations on corticosteroids, immunotherapy, and other novel treatment strategies.

CME-Certified Video Module:

Idiopathic Thrombocytopenic Purpura: Shifting the Treatment Paradigm
In this CME-certified video, Howard Liebman, MD, provides a comprehensive overview of the pathology and treatment of immune thrombocytopenia.

Downloadable PowerPoint Slidesets:

Pathophysiology of ITP
This downloadable slideset provides a pathology overview of primary and secondary immune thrombocytopenia.
Standard Drug Treatments for Primary Immune Thrombocytopenia
This downloadable slideset provides an overview of standard treatment options for patients with immune thrombocytopenia.
Advances in Immunotherapy Approaches to ITP
This downloadable slideset provides an overview of high-dose dexamethasone, rituximab, veltuzumab therapies for immune thrombocytopenia.
Targeting Growth Factors for the Management of ITP
This downloadable slideset gives an overview of the rationale for the targeting of the thrombopoietin receptor and the clinical application of this approach in ITP.
Bringing It All Together: Guidelines & Expert Recommendations Based on Diagnostic & Treatment Advances
This downloadable slideset provides an overview of recently published treatment recommendations for patients with immune thrombocytopenia.
Future Therapy for ITP: What’s Next?
This downloadable slideset provides insights into research directions in ITP.

Treatment Update

Practice in Evolution: Optimal Management of NSCLC 

This new CME/CE-certified Treatment Update includes journal article reviews, case discussion, video, and downloadable slidesets presenting the latest data in non-small-cell lung cancer treatment.


Now Available!

Journal Article Reviews:

  • Gefitinib vs Carboplatin-Paclitaxel in First-line Treatment of Advanced Pulmonary Adenocarcinoma: Results From the Phase III IPASS Study
    Mok TS, et al. NEJM. 2009;361:947-957. 
    Capsule SummaryExpert Commentary | Slides
  • Surgical Resection After Concurrent Chemotherapy and Radiotherapy Associated With Improved PFS, but Not Improved OS in Non-Small-Cell Lung Cancer
    Albain KS, et al. Lancet. 2009;374:379-386. 
    Capsule Summary | Expert Commentary | Slides

CME-Certified Module:

/upload/global/headshots/herbst_roy.jpg/upload/global/headshots/sandler_alan.jpg Cases Cubed: 3 Cases, 3 Expert Opinions in Non-Small-Cell Lung Cancer
Roy S. Herbst, MD, PhD; Vincent A. Miller, MD; and Alan B. Sandler, MD, present and discuss 3 case studies highlighting the factors that go into making challenging non-small-lung cancer treatment decisions, with particular consideration of biomarker analysis, use of adjuvant therapy, and maintenance therapy.

Downloadable PowerPoint Slidesets:

Selected Currently Enrolling Phase III Clinical Trials in NSCLC
Download PowerPoint slides highlighting the key features of a selection of the largest active multicenter phase III trials in NSCLC.


CME-Certified Video Module:

/upload/global/headshots/herbst_roy.jpg

Practice in Evolution: Recent Advances in the Treatment of NSCLC
Roy S. Herbst, MD, PhD, discusses the clinical implications of recently published or presented data on the treatment of non-small-cell lung cancer.

Treatment Update

Evolutions in VEGF-Targeted Therapy for GBM: Recent Advances and Ongoing Research

Through a CME-certified didactic text module and 3 Interactive Virtual Presentations, CCO’s expert faculty members explore new thinking and recent findings regarding anti-VEGF strategies in the treatment of glioblastoma.


CME-Certified Module:
The Changing Landscape of Glioblastoma Multiforme

James J. Vredenburgh, MD, reviews the biology of glioblastomas and discusses currently available and investigational anti-VEGF therapies for this disease. Click here to begin.

CME-Certified Interactive Virtual Presentations:
Expanding Treatment Options for Glioblastoma: Past, Present, and Future

/upload/global/headshots/cloughesy_timothy.jpg In this case-based Interactive Virtual Presentation, Timothy Cloughesy, MD, discusses current data in current treatment modalities for patients with glioblastoma. Click here to begin.

Expanding Treatment Options for Glioblastoma: Past, Present, and Future

Download slides on the most recurrent data in glioblastoma therapies. Click here to download slides.

Optimizing Patient Outcomes With Angiogenic Inhibitors for the Treatment of GBM

Laurie Rice, RN, MSN, NP, highlights optimal strategies for preventing and coping with potential adverse events during antiangiogenesis therapy for glioblastoma. Click here to begin.

Optimizing Patient Outcomes With Angiogenic Inhibitors for the Treatment of GBM

Laurie Rice, RN, MSN, NP, provides an overview of monitoring and management strategies for adverse events associated with antiangiogenesis therapy in patients with glioblastoma. Click here to download slides.

Treatment Update

Disrupting the Cell Cycle: Microtubule-Targeted Therapies in Metastatic Breast Cancer

This slideset, presented at a CCO satellite symposium in San Antonio, Texas, reviews important clinical data in microtubule-targeted therapies in metastatic breast cancer.

Downloadable PowerPoint Slideset:
Disrupting the Cell Cycle: Microtubule-Targeted Therapies in Metastatic Breast Cancer
Downloadable slides on the role of microtubule-targeted therapies in metastatic breast cancer.

Treatment Update

Evolving Treatment Paradigms for GIST: Current Approaches and Agents on the Horizon

In this CME-certified Treatment Update, Ricardo J. Gonzalez, MD, and Jonathan C. Trent, MD, PhD, explore changes in treatment of gastrointestinal stromal tumors.

CME-Certified Module:

Gastrointestinal Stromal Tumors
Ricardo J. Gonzalez, MD, explores the biology of gastrointestinal tumors, the currently available treatment options, and the novel agents under investigation for this disease.

Interactive Virtual Presentation:

Optimal Treatment Approaches for GIST
Watch, listen, and make treatment decisions as Jonathan C. Trent, MD, PhD, leads you through a case-based interactive presentation exploring the best strategies for treating patients with GIST.

Treatment Update

Application of Novel Approaches to Treatment of Chronic Immune (Idiopathic)Thrombocytopenia

This CME-certified educational program provides an overview of the diagnosis and pathology of immune thrombocytopenia as well as discussion of evolving treatment approaches by expert faculty members James B. Bussel, MD, and Keith R. McCrae, MD.

Now Available!

CME-Certified Module:
Advances in the Management of Patients With Immune Thrombocytopenia

James B. Bussel, MD reviews the pathology, diagnosis, and treatment of immune thrombocytopenia. Click here to begin.

CME-Certified Interactive Virtual Presentation:
Immune Thrombocytopenia: Diagnosis, Pathogenesis, and Management
Keith R. McCrae, MD, provides an overview of the diagnosis and pathology of immune thrombocytopenia (ITP) then discusses eveloving treatment approaches for the management of ITP. Click here to begin.

Downloadable PowerPoint Slideset:

This downloadable slideset provides an overview of immune thrombocytopenia including pathology and diagnosis with case scenarios highlighting optimal management strategies for patients with primary immune thrombocytopenia. Click here to download slides.

Treatment Update

Myelodysplastic Syndromes: Integrating Novel Agents Into Current Treatment Algorithms 

Review a comprehensive text-based module on recent advances in the diagnosis, classification, and treatment of MDS; use the interactive MDS tool to help guide treatment choices tailored to your specific patient.

CME-Certified Module:

/upload/global/headshots/galili_n.jpg/upload/global/headshots/raza_azra.jpg Understanding Myelodysplastic Syndromes: Diagnosis, Classification, and Treatment
Naomi Galili, PhD, and Azra Raza, MD, discuss recent advances in the diagnosis, classification, and treatment of MDS.

Interactive Decision Support Tool:

Treatment Recommendations for Patients With Myelodysplastic Syndrome
This interactive decision support tool is designed to determine optimal treatment recommendations for a patient with myelodysplastic syndrome based on treatment guidelines and expert faculty input.

Treatment Update

Novel Therapeutic Research and Priority Trials in Breast Cancer: An Online Clinical Management Series 

This new CME-certified Treatment Update, produced in collaboration with the Coalition of Cancer Cooperative Groups, includes a Virtual Presentation, downloadable slideset, and white paper reviewing high-priority research areas and clinical trials in breast cancer.


Now Available!

CME-Certified Virtual Presentation:

/upload/global/headshots/perez_edith.jpg SLC Consensus on Research Priorities in Breast Cancer
In this Interactive Virtual Presentation, Edith A. Perez, MD, reviews high-priority research areas and clinical trials in breast cancer, as identified by the Breast Cancer Scientific Leadership Council.

Downloadable PowerPoint Slideset:

SLC Consensus on Research Priorities in Breast Cancer: Meeting Overview
Downloadable slideset which reviews the high-priority research areas and clinical trials in breast cancer, as identified by the Breast Cancer Scientific Leadership Council. Click here to download slides.

Downloadable White Paper:

Research Priorities in Breast Cancer: Recommendations of the Scientific Leadership Council in Breast Cancer of the Coalition of Cancer Cooperative Groups
Download PDF of white paper produced on recommendations of the SLC in Breast Cancer as presented at the Coalition of Cancer Cooperative Groups meeting in September 2008. Click here to download worksheet.

Treatment Update

Idiopathic Thrombocytopenic Purpura (ITP): Shifting the Treatment Paradigm

Explore recent findings on immune thrombocytopenia (ITP) through a video module* and 6 downloadable slidesets. Topics include ITP etiology, pathophysiology, standard and new treatment strategies, recent expert recommendations, and future directions.


Downloadable PowerPoint Slidesets:

Pathophysiology of ITP
This downloadable slideset provides a pathology overview of primary and secondary immune thrombocytopenia. Click here to download slides.

Standard Drug Treatments for Primary Immune Thrombocytopenia
This downloadable slideset provides an overview of standard treatment options for patients with immune thrombocytopenia. Click here to download slides.

Advances in Immunotherapy Approaches to ITP
This downloadable slideset provides an overview of high-dose dexamethasone, rituximab, veltuzumab therapies for immune thrombocytopenia. Click here to download slides.

Targeting Growth Factors for the Management of ITP
This downloadable slideset gives an overview of the rationale for the targeting of the thrombopoietin receptor and the clinical application of this approach in ITP. Click here to download slides.

Bringing It All Together: Guidelines & Expert Recommendations Based on Diagnostic & Treatment Advances
This downloadable slideset provides an overview of recently published treatment recommendations for patients with immune thrombocytopenia. Click here to download slides.

Future Therapy for ITP: What’s Next?
This downloadable slideset provides insights into research directions in ITP. Click here to download slides.


Coming Soon!

CME-Certified Video Module:

Overview of the Causes and Treatments for ITP

CCO Conference Coverage

Joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO)

Join CCO’s expert faculty members as they review the clinical implications of research on gastrointestinal, genitourinary, breast, and lung cancers presented at the 2009 ECCO/ESMO Congress.


CME-Certified Conference Reports:
Breast and Lung Cancers

Gunter von Minckwitz, MD, PhD, and Giuseppe Giaccone, MD, PhD, discuss the most clinically relevant abstracts on lung cancer and breast cancer presented at the joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO). Click here to begin.


Gastrointestinal and Genitourinary Cancers

Josep Tabernero, MD, and Bernard Escudier, MD, discuss the most clinically relevant abstracts on gastrointestinal cancer and genitourinary cancer presented at the joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO). Click here to begin.

Treatment Update

A Call to Action for Hematology Fellows: Clinical Advances and Patient Considerations in Lymphomas

Through a didactic module, an Interactive Virtual Presentation, and a downloadable slideset, explore current optimal treatment strategies for non-Hodgkin’s lymphomas.

CME-Certified Module:

A Call to Action for Hematology Fellows: Clinical Advances and Patient Considerations in Lymphomas
Alissa Marr, MD, and James O. Armitage, MD, provide an overview of non-Hodgkin’s lymphoma for oncology/hematology fellows.

CME-Certified Interactive Virtual Presentation:

Therapeutic Approaches in Non-Hodgkin’s Lymphoma: A Case Review
James O. Armitage, MD, and Alissa Marr, MD, provide a case-based analysis of optimal management strategies for non-Hodgkin’s lymphoma with an emphasis on diagnosis, prognostic assessment, and treatment.

Downloadable PowerPoint Slideset:

Therapeutic Approaches in Non-Hodgkin’s Lymphoma: A Case Review
Review a case-based analysis of optimal management strategies for non-Hodgkin’s lymphoma with an emphasis on diagnosis, prognostic assessment, and treatment.

Treatment Update

Practice in Evolution: Optimal Management of Colorectal Cancer

Explore the optimal clinical management of colorectal cancer through 2 journal article reviews, an expert case discussion, a downloadable slideset, and a video module.

Journal Article Reviews:

CME-Certified Module:

/upload/global/headshots/grothey_axel.jpg/upload/global/headshots/eng_cathy.jpg/upload/global/headshots/goldberg_richard.jpg

Cases Cubed: 3 Cases, 3 Expert Opinions in Colorectal Cancer
In this Expert Case Discussion, Axel Grothey, MD; Cathy Eng, MD; Richard M. Goldberg, MD; and Nancy Roach explore current thinking regarding the clinical management of patients with colorectal cancer in 3 case scenarios.

Downloadable PowerPoint Slideset:

Selected Currently Enrolling Phase II/III Clinical Trials in CRC
Download slides on currently enrolling phase II/III clinical trials in colorectal cancer.

CME-Certified Video Module:

/upload/global/headshots/benson_al.jpg

Clinical Implications of Recent Data on the Community Oncologist
Al B. Benson, III, MD, FACP, discusses the impact of recent data in colorectal cancer including findings from the QUASAR validation study, NSABP C-08, ACCENT, STEPP, and other phase III trials on clinical practice.

Treatment Update

Novel Mechanisms of Action in Adjuvant Therapy: Bisphosphonates and Targeted Agents in Solid Tumors

In this new Treatment Update, CCO’s expert faculty members discuss the biological effect of bisphosphonates and their clinical rationale in the adjuvant treatment of breast cancer and other solid tumors.

CME-Certified Modules:

Expanding the Targets in Adjuvant Therapy
Adam M. Brufsky, MD, PhD, provides an overview of targeted therapies in multiple tumor types.

Bisphosphonates: Rationale for Use as Adjuvant Therapy
Adam M. Brufsky, MD, PhD, provides an overview of the potential mechanisms by which bisphosphonates may block metastasis, prevent bone destruction, inhibit tumor growth, and stimulate host immune mechanisms.

Clinical Data on the Use of Bisphosphonates in the Adjuvant Treatment of Breast Cancer
Michael Gnant, MD, reviews the mechanisms of action of bisphosphonates and summarizes the results of several recent breast cancer clinical trials investigating the effect of bisphosphonate therapy on bone health, metastasis, tumor burden, and survival.

Beyond Breast Cancer: An Update on Bisphosphonates for Prostate Cancer
Matthew R. Smith, MD, PhD, reviews clinical data regarding the adjuvant use of bisphosphonates in the treatment of patients with prostate cancer.

Interactive Dialogue Session: Clinical Considerations and Debates in Adjuvant Therapy
Adam M. Brufsky, MD, PhD; Michael Gnant, MD; and Matthew R. Smith, MD, PhD, present cases and clinical questions regarding the use of bisphosphonates and targeted therapies for treating breast and prostate cancer patients in the adjuvant setting.

CCO Conference Coverage

2009 World Conference on Lung Cancer


CME-Certified Conference Report:

/upload/global/headshots/vokes_everett.jpg/upload/global/headshots/west_howard.jpg Emerging Data in Lung Cancer 2009
Everett Vokes, MD, and Howard (Jack) L. West, MD, discuss the most clinically relevant data from the lung cancer conference in San Francisco, California.

Treatment Update

Novel Strategies for Bone-Directed Therapy Across the Cancer Continuum


Downloadable PowerPoint Slideset:

Novel Strategies for Bone-Directed Therapy Across the Cancer Continuum
Download slides from the independent symposium presented for attendees of the IX International Meeting on Cancer-Induced Bone Disease by .Allan Lipton, MD; Robert E. Coleman, MD, FRCP; G. David Roodman, MD, PhD; and Matthew R. Smith, MD, PhD on October 29, 2009.

Treatment Update

Master Class on Evolving Evidence and Emerging Treatments: Targeted Agents in Advanced Renal Cell Carcinoma


CME-Certified Interactive Virtual Presentation:
Master Class on Evolving Evidence and Emerging Treatments: Targeted Agents in Advanced Renal Cell Carcinoma

/upload/global/headshots/rini_brian.jpg Brian I. Rini, MD, discusses current thinking regarding the use of targeted agents in the treatment of kidney cancer.


CCO Slideset:
Master Class on Evolving Evidence and Emerging Treatments: Targeted Agents in Advanced Renal Cell Carcinoma

Download a presentation by Brian I. Rini, MD, in which he recaps the discussions from a Master Class Symposium on current treatment strategies in RCC. Click here to download slides.

CCO Conference Coverage

2009 American Association for Cancer Research Annual Meeting


CME-Certified Conference Report:

/upload/global/headshots/herbst_roy.jpg/upload/global/headshots/hidalgo_manuel.jpg Breakthroughs in Cancer Research 2009
Join Roy S. Herbst, MD, PhD, and Manuel Hidalgo, MD, PhD, as they review clinical implications of breakthroughs in cancer research presented at the 2009 American Association for Cancer Research Annual Meeting.

Management Series

Practical Applications and Clinical Advances in Multiple Myeloma

Through 2 didactic modules, 3 Interactive Virtual Presentations, and a downloadable slideset, CCO’s expert faculty members explore recent data and clinical considerations that affect outcomes in the setting of multiple myeloma.

CME/CE-Certified Modules:

Mechanisms of Action and Clinical Advances in the Treatment of Multiple Myeloma
R. Donald Harvey, PharmD, FCCP, BCPS, BCOP, and Joseph D. Tariman, PhC, APRN, BC, OCN, review safety, efficacy, and mechanistic data on current and potential future treatment options for patients with multiple myeloma.

Clinical Considerations and Implications for Optimizing Patient Outcomes in Multiple Myeloma
R. Donald Harvey, PharmD, FCCP, BCPS, BCOP, and Joseph D. Tariman, PhC, MN, APRN, BC, OCN, review nursing considerations and strategies to manage adverse events of current and emerging treatments for patients with multiple myeloma.


CME-Certified Interactive Virtual Presentation:

/upload/global/headshots/harousseau.jpg

Newly Diagnosed Multiple Myeloma in Transplantation-Eligible Patients
Jean-Luc Harousseau, MD, explores recent thinking and new clinical trial data shaping the treatment of myeloma patients who are eligible for stem cell transplantation.

/upload/global/headshots/san-miguel_jesus.jpg

Treatment of Newly Diagnosed Myeloma Patients Who Are Not Candidates for ASCT
In this interactive program, Jesús F. San Miguel, MD, PhD, discusses optimal treatment approaches for myeloma patients ineligible for transplantation and provides evidence-based data supporting these choices.

/upload/global/headshots/orlowski_robert.jpg

Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Robert Z. Orlowski, MD, PhD, explores optimal treatment approaches for patients with relapsed/refractory multiple myeloma and reviews supporting evidence in this interactive presentation.

Downloadable PowerPoint Slidesets:

Newly Diagnosed Multiple Myeloma in Transplantation-Eligible Patients
Download a presentation by Jean-Luc Harousseau, MD, to review frontline treatment strategies to optimize outcomes in patients with multiple myeloma who are candidates for autologous stem cell transplantation. Click here to download slides.

Treatment of Newly Diagnosed Myeloma Patients Who Are Not Candidates for ASCT
Download a presentation by Jesús F. San Miguel, MD, PhD, to explore optimal treatment approaches for myeloma patients ineligible for transplantation and review evidence-based data supporting these choices. Click here to download slides.

Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Explore optimal treatment approaches for patients with relapsed/refractory multiple myeloma and review supporting evidence with Robert Z. Orlowski, MD, PhD in this downloadable slide presentation. Click here to download slides.

Pharmacological and Clinical Nursing Considerations in the Treatment of Multiple Myeloma
Download a presentation by R. Donald Harvey, PharmD, FCCP, BCPS, BCOP, and Joseph D. Tariman, PhC, MN, APRN, BC, OCN, to review the pharmacologic profiles of agents for the treatment of myeloma and strategies to manage adverse events to optimize treatment outcomes for patients with multiple myeloma. Click here to download slides.

Treatment Update

Ovarian Cancer—Recent Developments in the Standard of Care and Emerging Options

Through 3 Interactive Virtual Presentations and associated downloadable slidesets, CCO’s expert faculty members explore current thinking and recent data that are shaping the future of ovarian cancer treatment.

CME-Certified Virtual Presentations:

/upload/global/headshots/thigpen_tate.jpg/upload/global/headshots/herzog_thomas.jpg

I. Frontline Management—IP and Maintenance Therapy
II. Rising CA-125: To Treat or Not to Treat?

This presentation consists of 2 talks. In the first talk, J. Tate Thigpen, MD, discusses the use of intraperitoneal and maintenance therapies in the frontline management of ovarian cancer; in the second talk, Thomas J. Herzog, MD, explores the controversies surrounding the role of rising CA-125 levels in ovarian cancer.

/upload/global/headshots/monk_bradley.jpg/upload/global/headshots/thigpen_tate.jpg

I. Platinum-Resistant Recurrent Disease
II. The Role of Platinum Doublets in Platinum-Sensitive Recurrent Disease

This presentation consists of 2 separate talks. In the first, Bradley J. Monk, MD, FACOG, FACS, explores current and novel treatment approaches for platinum-resistant recurrent ovarian cancer. In the second talk, J. Tate Thigpen, MD, discusses the role of platinum doublets in the management of patients with platinum-sensitive recurrent ovarian cancer.

/upload/global/headshots/monk_bradley.jpg/upload/global/headshots/herzog_thomas.jpg

I. Platinum-Sensitive Recurrent Ovarian Cancer (Nonplatinum Doublets)
II. Platinum-Sensitive Recurrent Disease: Role of Biologics and Secondary Cytoreduction

This virtual presentation consists of 2 talks in platinum-sensitive recurrent ovarian cancer. Bradley J. Monk, MD, FACOG, FACS, discusses the role of nonplatinum doublets in the first talk, and Thomas J. Herzog, MD, explores biologics and secondary cytoreduction in the second talk.

Downloadable PowerPoint Slidesets:

I. Frontline Management: IP and Maintenance Therapy. II. Rising CA-125: To Treat or Not to Treat?
Download slides on IP and maintenance therapy in ovarian cancer and of the role of CA-125 in this disease for use in your noncommercial presentations.

I. Platinum-Resistant Recurrent Disease. II. The Role of Platinum Doublets in Platinum-Sensitive Recurrent Disease
Download slides on treatment options in platinum-resistant recurrent ovarian cancer and on the use of platinum doublets in treating patients with platinum-sensitive disease.

I. Platinum-Sensitive Recurrent Ovarian Cancer (Nonplatinum Doublets). II. Platinum-Sensitive Recurrent Disease: Role of Biologics and Secondary Cytoreduction?
View slides on recent data on the use of nonplatinum doublets in platinum-sensitive recurrent ovarian cancer and on the roles of biologic agents and secondary cytoreduction in recurrent disease.

CCO Conference Coverage

2009 Oncology Nursing Society Annual Congress

In this Conference Report, CCO’s expert faculty members review results regarding novel therapies and supportive care strategies presented at the 2009 Oncology Nursing Society Annual Congress.

CME-Certified Conference Report:

Novel Therapies and Supportive Care
Carrie Daly, RN, MS, AOCN, and Marilyn Haas, PhD, RN, CNS, ANP-BC, summarize the highlights on novel treatments and supportive care from the 2009 Oncology Nursing Society Congress.

Treatment Update

Allogeneic Transplantation: Applying New Research for Improved Outcomes 

In this CME-certified Treatment Update, produced by CCO and the National Marrow Donor Program, CCO’s expert faculty members explore when allogeneic transplantation should be considered, what factors influence outcomes, the effect of age on patient eligibility, and recent advances in HLA matching.



CME-Certified Virtual Presentations:

Comparing Outcomes of Related and Unrelated Transplantations
Claudio Anasetti, MD, summarizes research that compares outcomes of related and unrelated donor transplants.
Comparing Outcomes of Related and Unrelated Transplants
Download slides in which Claudio Anasetti, MD compares outcomes from related and unrelated HLA-matched allogeneic stem cell transplantation.

Transplantation from Unrelated Donors: Factors That Influence Outcomes and Graft Choices
Mary Horowitz, MD, explains the influence of patient and donor factors on unrelated transplant outcomes.
Transplantation from Unrelated Donors: Factors That Influence Outcomes – and Graft Choices
Download slides in which Mary Horowitz, MD explains which donor and recipient factors affect outcomes in hematopoietic stem cell transplantations from unrelated donors.

Advances in HLA Matching for Unrelated Donor Transplantation
Dennis L. Confer, MD, explains advances in HLA typing including clinical and technology innovations.
Advances in HLA Matching for Unrelated Donor Transplantation
Download slides in which Dennis L. Confer, MD, explains the work of the National Marrow Donor Program and describes advances in HLA typing.

Treatment Update

Advances in the Management of Bone Health and Skeletal Complications in Cancer


CME/CE-Certified Interactive Virtual Presentations:

Advances in the Management of Bone Health in Multiple Myeloma

/upload/global/headshots/berenson_james.jpg James Berenson, MD, presents cases to illustrate key concepts of bone health in cancer patients, particularly those with multiple myeloma. Click here to begin.

Advances in the Management of Bone Health in Prostate Cancer

Matthew R. Smith, MD, PhD, reviews the current standard of care and emerging treatment options for prostate cancer patients at risk for bone disease. Click here to begin.

Bone Health and Skeletal Complications in Breast Cancer

Robert E. Coleman, MD, FRCP, reviews the current standards of care and emerging treatment options for breast cancer patients at risk for bone disease.
 


CCO Downloadable Slidesets:

Advances in the Management of Bone Health in Multiple Myeloma
Review the incidence, pathophysiology, and current management of bone complications in multiple myeloma patients. In addition emerging targeted therapies and their modes of action are discussed. Click here to download slides.

Advances in the Management of Bone Health in Prostate Cancer
Review the current standard of care and examine emerging treatment options for prostate cancer patients at risk of bone disease. Click here to download slides.

Bone Health and Skeletal Complications in Breast Cancer
Review the current standard of care and examine emerging treatment options for breast cancer patients at risk of skeletal complications and bone metastasis. Click here to download slides.

CCO Conference Coverage

Highlights of the 12th International Myeloma Workshop: A Video-Based Educational Program


CME-Certified Video Modules:

Treatment Update

7th International Symposium on Translational Research in Oncology


CME-Certified Modules:

7th International Symposium on Translational Research in Oncology

/upload/global/headshots/slamon_dennis.jpg/upload/global/headshots/crown_john.jpg

Highlights from the 2008 Translational Research meeting.


CCO Downloadable Slideset:

7th International Symposium on Translational Research

Downloadable slideset on highlights in translational research focused on new pathways and drug targets in oncology.

Treatment Update

Evolving Treatment Options and Future Directions in Mantle Cell Lymphoma


CME-Certified Modules:

State-of-the-Art First-line Treatment of MCL: Current and Novel Approaches  

Andrew D. Zelenetz, MD, PhD, reviews the latest data on current and novel therapeutic approaches for frontline treatment of mantle cell lymphoma.

New Options for the Treatment of Relapsed Mantle Cell Lymphoma

Steven H. Bernstein, MD, explores current recommendations and options for the treatment of advanced mantle cell lymphoma and discusses what recent clinical trial results may signify for patients.

The Role of Maintenance Therapy and Individualization of Therapy in Mantle Cell Lymphoma

Sven de Vos, MD, PhD, reviews the current status of maintenance therapy for mantle cell lymphoma and explores new developments in prognostic measures and markers that may lead to the individualization of therapy.

Practical Nursing Management Considerations in Mantle Cell Lymphoma

Amy Goodrich, RN, MSN, CRNP-AC, reviews current strategies to optimally manage therapy-related adverse effects in patients with mantle cell lymphoma.


CCO Downloadable Slideset:

Practical Nursing Management Considerations in Mantle Cell Lymphoma

Download slides on important nursing considerations for patients who are receiving medical therapy for mantle cell lymphoma.

Treatment Update

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium 


CME-Certified Slideset Module:

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium
Expert faculty provide an overview of the bone microenvironment, treatment-related bone loss, prevention of metastatic disease, and evolving treatment options for managing bone health in prostate cancer patients.


Downloadable PowerPoint Slideset:

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium
Download slides focused on the mechanisms underlying the bone microenvironment and how to best manage bone health and skeletal-related events in prostate cancer patients.

CCO Conference Coverage

2009 American Society of Clinical Oncology Annual Meeting

CCO's independent coverage of the 2009 Clinical Oncology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio Expert Highlights that focus on key issues highlighted at the conference.

  • Breast Cancer
    Robert S. Mocharnuk, MD, William J. Gradishar, MD, FACP, Kathy D. Miller, MD, Mark D. Pegram, MD 
  • Colorectal Cancer
    Anthony El-Khoueiry, MD, Edward Chu, MD, Richard M. Goldberg, MD, Alan P. Venook, MD, Anthony El-Khoueiry, MD
  • Hematologic Malignancies
    Edward A. Stadtmauer, MD, Kenneth Anderson, MD, Andre Goy, MD, Susan M. O’Brien, MD
  • Lung Cancer
    Barbara J. Gitlitz, MD, David R. Gandara, MD, Ramaswamy Govindan, MD, Corey J. Langer, MD, FACP

More Treatment Updates

Hematology

Oncology

More CCO Independent Conference Coverage




Quickly access answers to your point-of-care questions



LATEST UPDATES:

Metastatic Non-Small-Cell Lung Cancer: Updated to reflect ASCO clinical practice guideline updates for chemotherapy for stage IV NSCLC. 

Nonmelanoma Skin Cancers: Updated to include romidepsin, a newly FDA-approved systemic treatment for relapsed/refractory cutaneous T-cell lymphoma.

Browse Oncology

Resource Center


This resource has been specific designed to meet the educational needs of oncology nurses. Check regularly for the latest conference coverage, treatment updates and plenty of free CE hours. Click here.

New Data

BIG 1-98 Substudy: Cognitive Function Better for Adjuvant Letrozole vs Tamoxifen in Early-Stage, Postmenopausal Breast Cancer Patients


Treatment with letrozole was associated with better cognitive function during the fifth year of treatment compared with tamoxifen.


Click here for related capsule summaries

Expert Commentary

from our Advisory Board & leading experts

Expert Viewpoint for November 2009

By:

Ian Flinn, MD, PhD

Ian Flinn, MD, PhD

Program Director
Sarah Cannon Blood & Marrow Transplant Program
Tennessee Oncology
Nashville, Tennessee

More Expert Viewpoints

Resource Centers

Clinical Care Options Oncology Nursing Education

Access CCO's most compelling content on oncology nursing from a single convenient page